Skip to main content

Human Epidermal Growth Factor Receptor 2 (HER2) Antagonist Use in Patients with Live Birth Deliveries: A Descriptive Analysis

    Basic Details
    Date Posted
    Medical Product
    HER2 antagonists

    In this report, we describe cohorts of patients with live birth deliveries who had an exposure to Human Epidermal Growth Factor Receptor 2 (HER2) antagonist drugs in the IBM® MarketScan® Research Databases. The study period includes data from January 1, 2010 through September 30, 2019. We distributed this request to IBM® MarketScan® Research Databases on May 7, 2021.

    Additional Details
    FDA Center
    Time Period
    January 1, 2010 - September 30, 2019
    Analysis Type
    Population / Cohort
    Females 18 years of age and older
    Data Sources
    IBM® MarketScan® Research Databases